BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Julphar
Chinese Patent Office
Accenture
AstraZeneca
Teva
Novartis
Boehringer Ingelheim
UBS
Colorcon

Generated: January 19, 2018

DrugPatentWatch Database Preview

FLOXURIDINE Drug Profile

« Back to Dashboard

Which patents cover Floxuridine, and what generic alternatives are available?

Floxuridine is a drug marketed by Fresenius Kabi Usa and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in FLOXURIDINE is floxuridine. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the floxuridine profile page.
Drug patent expirations by year for FLOXURIDINE
Pharmacology for FLOXURIDINE
Ingredient-typeDeoxyuridine
Drug ClassAntimetabolite
Medical Subject Heading (MeSH) Categories for FLOXURIDINE

US Patents and Regulatory Information for FLOXURIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa FLOXURIDINE floxuridine INJECTABLE;INJECTION 075837-001 Feb 22, 2001 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int FLOXURIDINE floxuridine INJECTABLE;INJECTION 075387-001 Apr 16, 2000 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Deloitte
QuintilesIMS
AstraZeneca
Covington
Merck
Colorcon
Moodys
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot